Plain-English translation of NCT06999174 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study evaluates whether advanced MRI imaging—using specialized techniques that show how tumors function at a deeper level—can help doctors better diagnose and monitor liver cancer. Researchers want to see if these detailed scans can improve treatment decisions for patients receiving standard liver cancer treatments like chemoembolization or radiotherapy. You would have these scans performed at three specific time points during your treatment.
Current imaging methods don't always provide enough detail about how liver cancer will respond to treatment. This study aims to fill that gap by testing whether more advanced MRI techniques can give doctors better insights into tumor behavior and help them predict which patients will benefit most from their chosen treatment.
You likely qualify if…
You likely don't qualify if…
As a participant, you would receive MRI scans at three scheduled times—typically before treatment begins, during treatment, and after treatment ends—as part of your regular cancer care at the hospital. Each MRI scan takes about 30–60 minutes and uses advanced imaging techniques (no new or experimental drugs are involved). The scans will be reviewed by experienced radiologists, and your imaging results will help doctors understand how your tumor is responding to treatment.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Germany